PLYMOUTH MTG., Pa., April 2, 2019 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced the recipients of a series of awards honoring individuals whose significant contributions fueled progress in improving and facilitating quality, effective, efficient, and accessible cancer care over the past year.
- Timothy J. Eberlein, MD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
- Margaret A. Tempero, MD, UCSF Helen Diller Family Comprehensive Cancer Center
- Richard Hoppe, MD, Stanford Cancer Institute
- Michael Kolodziej, MD, ADVI
- Jennifer Burns, NCCN
Outgoing Board of Directors Chair Dr. Eberlein was presented with a Board of Producers Award. He was applauded for his reasonable and fair leadership approaches, his availability for advice, and his emphasis on fostering collaboration throughout the greater cancer care community.
"I think there are two components that make this organization unique: great leadership and a passionate staff," said Dr. Eberlein. "It's a privilege to be part of the positive impact NCCN has for millions who suffer from cancer all over the world."
Another Board of Producers Award went to Dr. Tempero in honor of her long history of contributions to NCCN, which include chairing the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Pancreatic Cancer, membership on various other panels, serving on 11 committees, involvement with the Policy Advisory Group, and helming JNCCN—Journal of the National Comprehensive Cancer Network as Editor-In-Chief since 2014.
"I'm so proud of this organization and feel privileged to have been a part since the very beginning," said Dr. Tempero, while receiving her award. "I have seen impressive innovation over the years while on this amazing journey with NCCN."
Dr. Hoppe received the Rodger Winn Award for expert judgment and commitment to excellence in service of the NCCN Guidelines®. As the founding Chair of the NCCN Guidelines Panel for Hodgkin Lymphoma and current member of two additional panels, Dr. Hoppe has earned a reputation for his collegial and respectful manner, compassion, thoughtfulness, and preparedness. The award is in memory of the first leader of the NCCN Guidelines program.
Dr. Kolodziej was honored as a Partner in Cancer Care in appreciation for his efforts to engage policymakers, employers, payers, and others to improve the accessibility of high-quality cancer care. He described his work with NCCN as "a tremendous responsibility, a tremendous honor, and one of the best parts of my career."
Jennifer Burns is a Guidelines Coordinator with NCCN's Clinical Information Operations team. She was named the Pat Daulerio Employee of the Year Award recipient by her peers at NCCN. The award—which honors the memory of a longtime employee in NCCN's Meetings department—is bestowed on a dedicated staff member who particularly exemplifies the Core Values of NCCN.
"I'm so grateful to be a small part of the mission I believe in so much," said Burns.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 28 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world.
The NCCN Member Institutions are: Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA; Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope National Medical Center, Duarte, CA; Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Comprehensive Cancer Center, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Rogel Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; University of Wisconsin Carbone Cancer Center, Madison, WI; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.
SOURCE National Comprehensive Cancer Network